Literature DB >> 20434811

Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines.

Viorela Pop1, Elizabeth Head, Nicole C Berchtold, Charles G Glabe, Christa M Studzinski, Adam M Weidner, M Paul Murphy, Carl W Cotman.   

Abstract

The aged canine is a higher animal model that naturally accumulates β-amyloid (Aβ) and shows age-related cognitive decline. However, profiles of Aβ accumulation in different species (40 vs. 42), its assembly states, and Aβ precursor protein (APP) processing as a function of age remain unexplored. In this study, we show that Aβ increases progressively with age as detected in extracellular plaques and biochemically extractable Aβ40 and Aβ42 species. Soluble oligomeric forms of the peptide, with specific increases in an Aβ oligomer migrating at 56 kDa, also increase with age. Changes in APP processing could potentially explain why Aβ accumulates, and we show age-related shifts toward decreased total APP protein and nonamyloidogenic (α-secretase) processing coupled with increased amyloidogenic (β-secretase) cleavage of APP. Importantly, we describe Aβ pathology in the cingulate and temporal cortex and provide a description of oligomeric Aβ across the canine lifespan. Our findings are in line with observations in the human brain, suggesting that canines are a valuable higher animal model for the study of Aβ pathogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434811      PMCID: PMC2932860          DOI: 10.1016/j.neurobiolaging.2010.02.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

1.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

3.  Region-specific age at onset of beta-amyloid in dogs.

Authors:  E Head; R McCleary; F F Hahn; N W Milgram; C W Cotman
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

4.  Oxidized neprilysin in aging and Alzheimer's disease brains.

Authors:  Deng-Shun Wang; Nobuhisa Iwata; Emi Hama; Takaomi C Saido; Dennis W Dickson
Journal:  Biochem Biophys Res Commun       Date:  2003-10-10       Impact factor: 3.575

5.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Authors:  Hiroaki Fukumoto; Bonnie S Cheung; Bradley T Hyman; Michael C Irizarry
Journal:  Arch Neurol       Date:  2002-09

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  alpha- and beta-secretase: profound changes in Alzheimer's disease.

Authors:  Susan J Tyler; David Dawbarn; Gordon K Wilcock; Shelley J Allen
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

Review 8.  Alzheimer's disease and the amyloid-beta peptide.

Authors:  M Paul Murphy; Harry LeVine
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Beta-secretase activity increases with aging in human, monkey, and mouse brain.

Authors:  Hiroaki Fukumoto; Douglas L Rosene; Mark B Moss; Susan Raju; Bradley T Hyman; Michael C Irizarry
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration.

Authors:  Lilian Calderón-Garcidueñas; Robert R Maronpot; Ricardo Torres-Jardon; Carlos Henríquez-Roldán; Robert Schoonhoven; Hilda Acuña-Ayala; Anna Villarreal-Calderón; Jun Nakamura; Reshan Fernando; William Reed; Biagio Azzarelli; James A Swenberg
Journal:  Toxicol Pathol       Date:  2003 Sep-Oct       Impact factor: 1.902

View more
  7 in total

1.  Early brain injury alters the blood-brain barrier phenotype in parallel with β-amyloid and cognitive changes in adulthood.

Authors:  Viorela Pop; Dane W Sorensen; Joel E Kamper; David O Ajao; M Paul Murphy; Elizabeth Head; Richard E Hartman; Jérôme Badaut
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

Review 2.  Aging in the canine and feline brain.

Authors:  Charles H Vite; Elizabeth Head
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-11-01       Impact factor: 2.093

3.  Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease.

Authors:  James L Searcy; Jeremiah T Phelps; Tristano Pancani; Inga Kadish; Jelena Popovic; Katie L Anderson; Tina L Beckett; Michael P Murphy; Kuey-Chu Chen; Eric M Blalock; Philip W Landfield; Nada M Porter; Olivier Thibault
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model.

Authors:  Sarah B Martin; Amy L S Dowling; Elizabeth Head
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

Review 5.  Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders.

Authors:  Mariarita Romanucci; Leonardo Della Salda
Journal:  Oxid Med Cell Longev       Date:  2015-05-11       Impact factor: 6.543

Review 6.  Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.

Authors:  Paulina R Davis; Elizabeth Head
Journal:  Front Pharmacol       Date:  2014-03-21       Impact factor: 5.810

7.  (E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates LPS-Mediated Memory Impairment by Inhibition of STAT3 Pathway.

Authors:  Ji Yeon Choi; Chul Ju Hwang; Do Yeon Lee; Sun Mi Gu; Hee Pom Lee; Dong Young Choi; Ki Wan Oh; Sang-Bae Han; Jin Tae Hong
Journal:  Neuromolecular Med       Date:  2017-10-19       Impact factor: 3.843

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.